A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.

MLA

Yokomizo, T., et al. “A Second Leukotriene B(4) Receptor, BLT2. A New Therapeutic Target in Inflammation and Immunological Disorders.” The Journal of Experimental Medicine, vol. 192, no. 3, Aug. 2000, pp. 421–32. EBSCOhost, https://doi.org/10.1084/jem.192.3.421.

APA

Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., & Shimizu, T. (2000). A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. The Journal of Experimental Medicine, 192(3), 421–432. https://doi.org/10.1084/jem.192.3.421

Chicago

Yokomizo, T, K Kato, K Terawaki, T Izumi, and T Shimizu. 2000. “A Second Leukotriene B(4) Receptor, BLT2. A New Therapeutic Target in Inflammation and Immunological Disorders.” The Journal of Experimental Medicine 192 (3): 421–32. doi:10.1084/jem.192.3.421.